JOURNAL OF INFECTION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1182840, encodeId=e73d1182840e3, content=感染领域顶级期刊，杂志要求高，投了好几篇都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Mon Jan 10 14:42:37 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115179, encodeId=2c9421151e987, content=刚刚一篇小修后被拒，要引以为戒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Feb 18 00:04:20 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157976, encodeId=46e9215e9763e, content=第一天with editor，第二天decision in process，这是要拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93dc2530521, createdName=124fe854m56暂无昵称, createdTime=Sat Sep 16 09:47:47 CST 2023, time=2023-09-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=830880, encodeId=c29c83088091, content=审稿速度:2.0 经验分享：本实验室在此期刊上投稿3篇，2篇中标。本人那篇3月15号投稿，5月15号收到初审意见，大修一次，15天后给小修意见，但小修后1个月才接受。大修中碰见了一位较为刁钻的审稿人，但意见对于提升文章质量确实有不小帮助，另一位审稿人比较仁慈，总体来说，此期刊不错！唯一缺点，周期偏慢，对于急于毕业或是评职称的人来说不太合适！建议首先对自己文章中的错误或漏洞尽量补齐，勿抱侥幸心理，否则耽误的是自己的时间（经验）！对于不在乎时间的人来说，毕竟是二区期刊的吸引力还是大大的，不妨试试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Thu Aug 20 09:50:11 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124634, encodeId=946d2124634a0, content=2周with ed了，希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sun Apr 09 20:33:11 CST 2023, time=2023-04-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165048, encodeId=a383216504817, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：急性胰腺炎;感染 经验分享：投的research letter,好像是没有送外审，编辑部自己就决定接收了，历时20余天，效率很高的杂志，希望越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Oct 26 15:22:41 CST 2023, time=2023-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2096617, encodeId=11d8209661e51, content=偏重的研究方向：猴痘 经验分享：发表letter是不是速度很快？正常投稿到接收一周左右？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Oct 28 09:32:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100065, encodeId=793f210006526, content=偏重的研究方向：新冠病毒 经验分享：兄弟们，这个杂志快吗？我现在在with editor这里呆了快一个月了？我需要催稿吗？感觉好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5d85446134, createdName=ms7000001127694544, createdTime=Sat Nov 12 12:39:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107187, encodeId=4757210e187bb, content=偏重的研究方向：传染病学 经验分享：终于升到一区to p. 恭喜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Dec 23 19:46:46 CST 2022, time=2022-12-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180489, encodeId=671d2180489ff, content=投稿一周后直接Decision in Process，已经十天了。。。拒稿这么墨迹吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed Jan 10 13:39:38 CST 2024, time=2024-01-10, status=1, ipAttribution=天津)]

2022-01-10 1de6caf9m07(暂无匿称)

感染领域顶级期刊，杂志要求高，投了好几篇都是秒拒

60 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=1182840, encodeId=e73d1182840e3, content=感染领域顶级期刊，杂志要求高，投了好几篇都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Mon Jan 10 14:42:37 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115179, encodeId=2c9421151e987, content=刚刚一篇小修后被拒，要引以为戒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Feb 18 00:04:20 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157976, encodeId=46e9215e9763e, content=第一天with editor，第二天decision in process，这是要拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93dc2530521, createdName=124fe854m56暂无昵称, createdTime=Sat Sep 16 09:47:47 CST 2023, time=2023-09-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=830880, encodeId=c29c83088091, content=审稿速度:2.0 经验分享：本实验室在此期刊上投稿3篇，2篇中标。本人那篇3月15号投稿，5月15号收到初审意见，大修一次，15天后给小修意见，但小修后1个月才接受。大修中碰见了一位较为刁钻的审稿人，但意见对于提升文章质量确实有不小帮助，另一位审稿人比较仁慈，总体来说，此期刊不错！唯一缺点，周期偏慢，对于急于毕业或是评职称的人来说不太合适！建议首先对自己文章中的错误或漏洞尽量补齐，勿抱侥幸心理，否则耽误的是自己的时间（经验）！对于不在乎时间的人来说，毕竟是二区期刊的吸引力还是大大的，不妨试试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Thu Aug 20 09:50:11 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124634, encodeId=946d2124634a0, content=2周with ed了，希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sun Apr 09 20:33:11 CST 2023, time=2023-04-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165048, encodeId=a383216504817, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：急性胰腺炎;感染 经验分享：投的research letter,好像是没有送外审，编辑部自己就决定接收了，历时20余天，效率很高的杂志，希望越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Oct 26 15:22:41 CST 2023, time=2023-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2096617, encodeId=11d8209661e51, content=偏重的研究方向：猴痘 经验分享：发表letter是不是速度很快？正常投稿到接收一周左右？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Oct 28 09:32:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100065, encodeId=793f210006526, content=偏重的研究方向：新冠病毒 经验分享：兄弟们，这个杂志快吗？我现在在with editor这里呆了快一个月了？我需要催稿吗？感觉好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5d85446134, createdName=ms7000001127694544, createdTime=Sat Nov 12 12:39:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107187, encodeId=4757210e187bb, content=偏重的研究方向：传染病学 经验分享：终于升到一区to p. 恭喜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Dec 23 19:46:46 CST 2022, time=2022-12-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180489, encodeId=671d2180489ff, content=投稿一周后直接Decision in Process，已经十天了。。。拒稿这么墨迹吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed Jan 10 13:39:38 CST 2024, time=2024-01-10, status=1, ipAttribution=天津)]

2023-02-18 osmataku 来自北京

刚刚一篇小修后被拒，要引以为戒了

76 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1182840, encodeId=e73d1182840e3, content=感染领域顶级期刊，杂志要求高，投了好几篇都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Mon Jan 10 14:42:37 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115179, encodeId=2c9421151e987, content=刚刚一篇小修后被拒，要引以为戒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Feb 18 00:04:20 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157976, encodeId=46e9215e9763e, content=第一天with editor，第二天decision in process，这是要拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93dc2530521, createdName=124fe854m56暂无昵称, createdTime=Sat Sep 16 09:47:47 CST 2023, time=2023-09-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=830880, encodeId=c29c83088091, content=审稿速度:2.0 经验分享：本实验室在此期刊上投稿3篇，2篇中标。本人那篇3月15号投稿，5月15号收到初审意见，大修一次，15天后给小修意见，但小修后1个月才接受。大修中碰见了一位较为刁钻的审稿人，但意见对于提升文章质量确实有不小帮助，另一位审稿人比较仁慈，总体来说，此期刊不错！唯一缺点，周期偏慢，对于急于毕业或是评职称的人来说不太合适！建议首先对自己文章中的错误或漏洞尽量补齐，勿抱侥幸心理，否则耽误的是自己的时间（经验）！对于不在乎时间的人来说，毕竟是二区期刊的吸引力还是大大的，不妨试试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Thu Aug 20 09:50:11 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124634, encodeId=946d2124634a0, content=2周with ed了，希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sun Apr 09 20:33:11 CST 2023, time=2023-04-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165048, encodeId=a383216504817, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：急性胰腺炎;感染 经验分享：投的research letter,好像是没有送外审，编辑部自己就决定接收了，历时20余天，效率很高的杂志，希望越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Oct 26 15:22:41 CST 2023, time=2023-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2096617, encodeId=11d8209661e51, content=偏重的研究方向：猴痘 经验分享：发表letter是不是速度很快？正常投稿到接收一周左右？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Oct 28 09:32:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100065, encodeId=793f210006526, content=偏重的研究方向：新冠病毒 经验分享：兄弟们，这个杂志快吗？我现在在with editor这里呆了快一个月了？我需要催稿吗？感觉好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5d85446134, createdName=ms7000001127694544, createdTime=Sat Nov 12 12:39:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107187, encodeId=4757210e187bb, content=偏重的研究方向：传染病学 经验分享：终于升到一区to p. 恭喜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Dec 23 19:46:46 CST 2022, time=2022-12-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180489, encodeId=671d2180489ff, content=投稿一周后直接Decision in Process，已经十天了。。。拒稿这么墨迹吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed Jan 10 13:39:38 CST 2024, time=2024-01-10, status=1, ipAttribution=天津)]

2023-09-16 124fe854m56暂无昵称来自浙江省

第一天with editor，第二天decision in process，这是要拒吗？

42 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1182840, encodeId=e73d1182840e3, content=感染领域顶级期刊，杂志要求高，投了好几篇都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Mon Jan 10 14:42:37 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115179, encodeId=2c9421151e987, content=刚刚一篇小修后被拒，要引以为戒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Feb 18 00:04:20 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157976, encodeId=46e9215e9763e, content=第一天with editor，第二天decision in process，这是要拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93dc2530521, createdName=124fe854m56暂无昵称, createdTime=Sat Sep 16 09:47:47 CST 2023, time=2023-09-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=830880, encodeId=c29c83088091, content=审稿速度:2.0 经验分享：本实验室在此期刊上投稿3篇，2篇中标。本人那篇3月15号投稿，5月15号收到初审意见，大修一次，15天后给小修意见，但小修后1个月才接受。大修中碰见了一位较为刁钻的审稿人，但意见对于提升文章质量确实有不小帮助，另一位审稿人比较仁慈，总体来说，此期刊不错！唯一缺点，周期偏慢，对于急于毕业或是评职称的人来说不太合适！建议首先对自己文章中的错误或漏洞尽量补齐，勿抱侥幸心理，否则耽误的是自己的时间（经验）！对于不在乎时间的人来说，毕竟是二区期刊的吸引力还是大大的，不妨试试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Thu Aug 20 09:50:11 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124634, encodeId=946d2124634a0, content=2周with ed了，希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sun Apr 09 20:33:11 CST 2023, time=2023-04-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165048, encodeId=a383216504817, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：急性胰腺炎;感染 经验分享：投的research letter,好像是没有送外审，编辑部自己就决定接收了，历时20余天，效率很高的杂志，希望越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Oct 26 15:22:41 CST 2023, time=2023-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2096617, encodeId=11d8209661e51, content=偏重的研究方向：猴痘 经验分享：发表letter是不是速度很快？正常投稿到接收一周左右？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Oct 28 09:32:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100065, encodeId=793f210006526, content=偏重的研究方向：新冠病毒 经验分享：兄弟们，这个杂志快吗？我现在在with editor这里呆了快一个月了？我需要催稿吗？感觉好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5d85446134, createdName=ms7000001127694544, createdTime=Sat Nov 12 12:39:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107187, encodeId=4757210e187bb, content=偏重的研究方向：传染病学 经验分享：终于升到一区to p. 恭喜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Dec 23 19:46:46 CST 2022, time=2022-12-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180489, encodeId=671d2180489ff, content=投稿一周后直接Decision in Process，已经十天了。。。拒稿这么墨迹吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed Jan 10 13:39:38 CST 2024, time=2024-01-10, status=1, ipAttribution=天津)]

2015-08-20 ms7999216884373889

审稿速度:2.0
经验分享：本实验室在此期刊上投稿3篇，2篇中标。本人那篇3月15号投稿，5月15号收到初审意见，大修一次，15天后给小修意见，但小修后1个月才接受。大修中碰见了一位较为刁钻的审稿人，但意见对于提升文章质量确实有不小帮助，另一位审稿人比较仁慈，总体来说，此期刊不错！唯一缺点，周期偏慢，对于急于毕业或是评职称的人来说不太合适！建议首先对自己文章中的错误或漏洞尽量补齐，勿抱侥幸心理，否则耽误的是自己的时间（经验）！对于不在乎时间的人来说，毕竟是二区期刊的吸引力还是大大的，不妨试试！

155 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1182840, encodeId=e73d1182840e3, content=感染领域顶级期刊，杂志要求高，投了好几篇都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Mon Jan 10 14:42:37 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115179, encodeId=2c9421151e987, content=刚刚一篇小修后被拒，要引以为戒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Feb 18 00:04:20 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157976, encodeId=46e9215e9763e, content=第一天with editor，第二天decision in process，这是要拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93dc2530521, createdName=124fe854m56暂无昵称, createdTime=Sat Sep 16 09:47:47 CST 2023, time=2023-09-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=830880, encodeId=c29c83088091, content=审稿速度:2.0 经验分享：本实验室在此期刊上投稿3篇，2篇中标。本人那篇3月15号投稿，5月15号收到初审意见，大修一次，15天后给小修意见，但小修后1个月才接受。大修中碰见了一位较为刁钻的审稿人，但意见对于提升文章质量确实有不小帮助，另一位审稿人比较仁慈，总体来说，此期刊不错！唯一缺点，周期偏慢，对于急于毕业或是评职称的人来说不太合适！建议首先对自己文章中的错误或漏洞尽量补齐，勿抱侥幸心理，否则耽误的是自己的时间（经验）！对于不在乎时间的人来说，毕竟是二区期刊的吸引力还是大大的，不妨试试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Thu Aug 20 09:50:11 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124634, encodeId=946d2124634a0, content=2周with ed了，希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sun Apr 09 20:33:11 CST 2023, time=2023-04-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165048, encodeId=a383216504817, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：急性胰腺炎;感染 经验分享：投的research letter,好像是没有送外审，编辑部自己就决定接收了，历时20余天，效率很高的杂志，希望越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Oct 26 15:22:41 CST 2023, time=2023-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2096617, encodeId=11d8209661e51, content=偏重的研究方向：猴痘 经验分享：发表letter是不是速度很快？正常投稿到接收一周左右？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Oct 28 09:32:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100065, encodeId=793f210006526, content=偏重的研究方向：新冠病毒 经验分享：兄弟们，这个杂志快吗？我现在在with editor这里呆了快一个月了？我需要催稿吗？感觉好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5d85446134, createdName=ms7000001127694544, createdTime=Sat Nov 12 12:39:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107187, encodeId=4757210e187bb, content=偏重的研究方向：传染病学 经验分享：终于升到一区to p. 恭喜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Dec 23 19:46:46 CST 2022, time=2022-12-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180489, encodeId=671d2180489ff, content=投稿一周后直接Decision in Process，已经十天了。。。拒稿这么墨迹吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed Jan 10 13:39:38 CST 2024, time=2024-01-10, status=1, ipAttribution=天津)]

2023-04-09 songgao 来自云南省

2周with ed了，希望能送外审

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1182840, encodeId=e73d1182840e3, content=感染领域顶级期刊，杂志要求高，投了好几篇都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Mon Jan 10 14:42:37 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115179, encodeId=2c9421151e987, content=刚刚一篇小修后被拒，要引以为戒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Feb 18 00:04:20 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157976, encodeId=46e9215e9763e, content=第一天with editor，第二天decision in process，这是要拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93dc2530521, createdName=124fe854m56暂无昵称, createdTime=Sat Sep 16 09:47:47 CST 2023, time=2023-09-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=830880, encodeId=c29c83088091, content=审稿速度:2.0 经验分享：本实验室在此期刊上投稿3篇，2篇中标。本人那篇3月15号投稿，5月15号收到初审意见，大修一次，15天后给小修意见，但小修后1个月才接受。大修中碰见了一位较为刁钻的审稿人，但意见对于提升文章质量确实有不小帮助，另一位审稿人比较仁慈，总体来说，此期刊不错！唯一缺点，周期偏慢，对于急于毕业或是评职称的人来说不太合适！建议首先对自己文章中的错误或漏洞尽量补齐，勿抱侥幸心理，否则耽误的是自己的时间（经验）！对于不在乎时间的人来说，毕竟是二区期刊的吸引力还是大大的，不妨试试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Thu Aug 20 09:50:11 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124634, encodeId=946d2124634a0, content=2周with ed了，希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sun Apr 09 20:33:11 CST 2023, time=2023-04-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165048, encodeId=a383216504817, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：急性胰腺炎;感染 经验分享：投的research letter,好像是没有送外审，编辑部自己就决定接收了，历时20余天，效率很高的杂志，希望越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Oct 26 15:22:41 CST 2023, time=2023-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2096617, encodeId=11d8209661e51, content=偏重的研究方向：猴痘 经验分享：发表letter是不是速度很快？正常投稿到接收一周左右？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Oct 28 09:32:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100065, encodeId=793f210006526, content=偏重的研究方向：新冠病毒 经验分享：兄弟们，这个杂志快吗？我现在在with editor这里呆了快一个月了？我需要催稿吗？感觉好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5d85446134, createdName=ms7000001127694544, createdTime=Sat Nov 12 12:39:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107187, encodeId=4757210e187bb, content=偏重的研究方向：传染病学 经验分享：终于升到一区to p. 恭喜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Dec 23 19:46:46 CST 2022, time=2022-12-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180489, encodeId=671d2180489ff, content=投稿一周后直接Decision in Process，已经十天了。。。拒稿这么墨迹吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed Jan 10 13:39:38 CST 2024, time=2024-01-10, status=1, ipAttribution=天津)]

2023-10-26 等月光倾城来自河南省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：急性胰腺炎;感染
经验分享：投的research letter,好像是没有送外审，编辑部自己就决定接收了，历时20余天，效率很高的杂志，希望越来越好！

32 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1182840, encodeId=e73d1182840e3, content=感染领域顶级期刊，杂志要求高，投了好几篇都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Mon Jan 10 14:42:37 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115179, encodeId=2c9421151e987, content=刚刚一篇小修后被拒，要引以为戒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Feb 18 00:04:20 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157976, encodeId=46e9215e9763e, content=第一天with editor，第二天decision in process，这是要拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93dc2530521, createdName=124fe854m56暂无昵称, createdTime=Sat Sep 16 09:47:47 CST 2023, time=2023-09-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=830880, encodeId=c29c83088091, content=审稿速度:2.0 经验分享：本实验室在此期刊上投稿3篇，2篇中标。本人那篇3月15号投稿，5月15号收到初审意见，大修一次，15天后给小修意见，但小修后1个月才接受。大修中碰见了一位较为刁钻的审稿人，但意见对于提升文章质量确实有不小帮助，另一位审稿人比较仁慈，总体来说，此期刊不错！唯一缺点，周期偏慢，对于急于毕业或是评职称的人来说不太合适！建议首先对自己文章中的错误或漏洞尽量补齐，勿抱侥幸心理，否则耽误的是自己的时间（经验）！对于不在乎时间的人来说，毕竟是二区期刊的吸引力还是大大的，不妨试试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Thu Aug 20 09:50:11 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124634, encodeId=946d2124634a0, content=2周with ed了，希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sun Apr 09 20:33:11 CST 2023, time=2023-04-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165048, encodeId=a383216504817, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：急性胰腺炎;感染 经验分享：投的research letter,好像是没有送外审，编辑部自己就决定接收了，历时20余天，效率很高的杂志，希望越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Oct 26 15:22:41 CST 2023, time=2023-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2096617, encodeId=11d8209661e51, content=偏重的研究方向：猴痘 经验分享：发表letter是不是速度很快？正常投稿到接收一周左右？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Oct 28 09:32:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100065, encodeId=793f210006526, content=偏重的研究方向：新冠病毒 经验分享：兄弟们，这个杂志快吗？我现在在with editor这里呆了快一个月了？我需要催稿吗？感觉好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5d85446134, createdName=ms7000001127694544, createdTime=Sat Nov 12 12:39:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107187, encodeId=4757210e187bb, content=偏重的研究方向：传染病学 经验分享：终于升到一区to p. 恭喜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Dec 23 19:46:46 CST 2022, time=2022-12-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180489, encodeId=671d2180489ff, content=投稿一周后直接Decision in Process，已经十天了。。。拒稿这么墨迹吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed Jan 10 13:39:38 CST 2024, time=2024-01-10, status=1, ipAttribution=天津)]

2022-10-28 ms8000001944553936

偏重的研究方向：猴痘
经验分享：发表letter是不是速度很快？正常投稿到接收一周左右？

58 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1182840, encodeId=e73d1182840e3, content=感染领域顶级期刊，杂志要求高，投了好几篇都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Mon Jan 10 14:42:37 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115179, encodeId=2c9421151e987, content=刚刚一篇小修后被拒，要引以为戒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Feb 18 00:04:20 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157976, encodeId=46e9215e9763e, content=第一天with editor，第二天decision in process，这是要拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93dc2530521, createdName=124fe854m56暂无昵称, createdTime=Sat Sep 16 09:47:47 CST 2023, time=2023-09-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=830880, encodeId=c29c83088091, content=审稿速度:2.0 经验分享：本实验室在此期刊上投稿3篇，2篇中标。本人那篇3月15号投稿，5月15号收到初审意见，大修一次，15天后给小修意见，但小修后1个月才接受。大修中碰见了一位较为刁钻的审稿人，但意见对于提升文章质量确实有不小帮助，另一位审稿人比较仁慈，总体来说，此期刊不错！唯一缺点，周期偏慢，对于急于毕业或是评职称的人来说不太合适！建议首先对自己文章中的错误或漏洞尽量补齐，勿抱侥幸心理，否则耽误的是自己的时间（经验）！对于不在乎时间的人来说，毕竟是二区期刊的吸引力还是大大的，不妨试试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Thu Aug 20 09:50:11 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124634, encodeId=946d2124634a0, content=2周with ed了，希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sun Apr 09 20:33:11 CST 2023, time=2023-04-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165048, encodeId=a383216504817, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：急性胰腺炎;感染 经验分享：投的research letter,好像是没有送外审，编辑部自己就决定接收了，历时20余天，效率很高的杂志，希望越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Oct 26 15:22:41 CST 2023, time=2023-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2096617, encodeId=11d8209661e51, content=偏重的研究方向：猴痘 经验分享：发表letter是不是速度很快？正常投稿到接收一周左右？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Oct 28 09:32:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100065, encodeId=793f210006526, content=偏重的研究方向：新冠病毒 经验分享：兄弟们，这个杂志快吗？我现在在with editor这里呆了快一个月了？我需要催稿吗？感觉好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5d85446134, createdName=ms7000001127694544, createdTime=Sat Nov 12 12:39:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107187, encodeId=4757210e187bb, content=偏重的研究方向：传染病学 经验分享：终于升到一区to p. 恭喜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Dec 23 19:46:46 CST 2022, time=2022-12-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180489, encodeId=671d2180489ff, content=投稿一周后直接Decision in Process，已经十天了。。。拒稿这么墨迹吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed Jan 10 13:39:38 CST 2024, time=2024-01-10, status=1, ipAttribution=天津)]

2022-11-12 ms7000001127694544

偏重的研究方向：新冠病毒
经验分享：兄弟们，这个杂志快吗？我现在在with editor这里呆了快一个月了？我需要催稿吗？感觉好慢啊

46 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1182840, encodeId=e73d1182840e3, content=感染领域顶级期刊，杂志要求高，投了好几篇都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Mon Jan 10 14:42:37 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115179, encodeId=2c9421151e987, content=刚刚一篇小修后被拒，要引以为戒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Feb 18 00:04:20 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157976, encodeId=46e9215e9763e, content=第一天with editor，第二天decision in process，这是要拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93dc2530521, createdName=124fe854m56暂无昵称, createdTime=Sat Sep 16 09:47:47 CST 2023, time=2023-09-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=830880, encodeId=c29c83088091, content=审稿速度:2.0 经验分享：本实验室在此期刊上投稿3篇，2篇中标。本人那篇3月15号投稿，5月15号收到初审意见，大修一次，15天后给小修意见，但小修后1个月才接受。大修中碰见了一位较为刁钻的审稿人，但意见对于提升文章质量确实有不小帮助，另一位审稿人比较仁慈，总体来说，此期刊不错！唯一缺点，周期偏慢，对于急于毕业或是评职称的人来说不太合适！建议首先对自己文章中的错误或漏洞尽量补齐，勿抱侥幸心理，否则耽误的是自己的时间（经验）！对于不在乎时间的人来说，毕竟是二区期刊的吸引力还是大大的，不妨试试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Thu Aug 20 09:50:11 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124634, encodeId=946d2124634a0, content=2周with ed了，希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sun Apr 09 20:33:11 CST 2023, time=2023-04-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165048, encodeId=a383216504817, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：急性胰腺炎;感染 经验分享：投的research letter,好像是没有送外审，编辑部自己就决定接收了，历时20余天，效率很高的杂志，希望越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Oct 26 15:22:41 CST 2023, time=2023-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2096617, encodeId=11d8209661e51, content=偏重的研究方向：猴痘 经验分享：发表letter是不是速度很快？正常投稿到接收一周左右？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Oct 28 09:32:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100065, encodeId=793f210006526, content=偏重的研究方向：新冠病毒 经验分享：兄弟们，这个杂志快吗？我现在在with editor这里呆了快一个月了？我需要催稿吗？感觉好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5d85446134, createdName=ms7000001127694544, createdTime=Sat Nov 12 12:39:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107187, encodeId=4757210e187bb, content=偏重的研究方向：传染病学 经验分享：终于升到一区to p. 恭喜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Dec 23 19:46:46 CST 2022, time=2022-12-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180489, encodeId=671d2180489ff, content=投稿一周后直接Decision in Process，已经十天了。。。拒稿这么墨迹吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed Jan 10 13:39:38 CST 2024, time=2024-01-10, status=1, ipAttribution=天津)]

2022-12-23 ms8000001944553936 来自福建省

偏重的研究方向：传染病学
经验分享：终于升到一区to p. 恭喜

44 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1182840, encodeId=e73d1182840e3, content=感染领域顶级期刊，杂志要求高，投了好几篇都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Mon Jan 10 14:42:37 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115179, encodeId=2c9421151e987, content=刚刚一篇小修后被拒，要引以为戒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Feb 18 00:04:20 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157976, encodeId=46e9215e9763e, content=第一天with editor，第二天decision in process，这是要拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93dc2530521, createdName=124fe854m56暂无昵称, createdTime=Sat Sep 16 09:47:47 CST 2023, time=2023-09-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=830880, encodeId=c29c83088091, content=审稿速度:2.0 经验分享：本实验室在此期刊上投稿3篇，2篇中标。本人那篇3月15号投稿，5月15号收到初审意见，大修一次，15天后给小修意见，但小修后1个月才接受。大修中碰见了一位较为刁钻的审稿人，但意见对于提升文章质量确实有不小帮助，另一位审稿人比较仁慈，总体来说，此期刊不错！唯一缺点，周期偏慢，对于急于毕业或是评职称的人来说不太合适！建议首先对自己文章中的错误或漏洞尽量补齐，勿抱侥幸心理，否则耽误的是自己的时间（经验）！对于不在乎时间的人来说，毕竟是二区期刊的吸引力还是大大的，不妨试试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Thu Aug 20 09:50:11 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124634, encodeId=946d2124634a0, content=2周with ed了，希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sun Apr 09 20:33:11 CST 2023, time=2023-04-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2165048, encodeId=a383216504817, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：急性胰腺炎;感染 经验分享：投的research letter,好像是没有送外审，编辑部自己就决定接收了，历时20余天，效率很高的杂志，希望越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Oct 26 15:22:41 CST 2023, time=2023-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2096617, encodeId=11d8209661e51, content=偏重的研究方向：猴痘 经验分享：发表letter是不是速度很快？正常投稿到接收一周左右？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Oct 28 09:32:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100065, encodeId=793f210006526, content=偏重的研究方向：新冠病毒 经验分享：兄弟们，这个杂志快吗？我现在在with editor这里呆了快一个月了？我需要催稿吗？感觉好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5d85446134, createdName=ms7000001127694544, createdTime=Sat Nov 12 12:39:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107187, encodeId=4757210e187bb, content=偏重的研究方向：传染病学 经验分享：终于升到一区to p. 恭喜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Fri Dec 23 19:46:46 CST 2022, time=2022-12-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180489, encodeId=671d2180489ff, content=投稿一周后直接Decision in Process，已经十天了。。。拒稿这么墨迹吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed Jan 10 13:39:38 CST 2024, time=2024-01-10, status=1, ipAttribution=天津)]

2024-01-10 ms5000000930127030 来自天津

投稿一周后直接Decision in Process，已经十天了。。。拒稿这么墨迹吗？

16 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务